Imad Naasani: The Pharmacokinetics of Genetic Vaccines
Speaking at General Assembly Meeting #62 on Monday, October 24, Imad Naasani gave a presentation about the pharmacokinetics of genetic vaccines, including the Covid-19 mRNA injections.
Who is Imad Naasani?
Imad Naasani, PhD is an experienced Chief Technology Officer with a demonstrated history of working in the nanotechnology and biomedical industry. He is a strong research professional, skilled in nanomaterials, drug development, pharmacology, cancer research, and biotechnology.
Naasani’s paper titled Establishing the Pharmacokinetics of Genetic Vaccines is Essential for Maximising their Safety and Efficacy was published in the peer-reviewed medical Clinical Pharmacokinetics on July 12, 2022. In this peer-reviewed article, Naasani explains why pharmacokinetics of genetic vaccines like the Covid-19 mRNA shots are so much different from those of traditional vaccines.
This is an edited segment from the weekly live General Assembly meeting on October 24, 2022.